1. Home
  2. LIF vs MMED Comparison

LIF vs MMED Comparison

Compare LIF & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$49.07

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIF
MMED
Founded
2008
1983
Country
United States
United States
Employees
547
2800
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.3B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
LIF
MMED
Price
$49.07
$16.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
10
Target Price
$75.58
$22.56
AVG Volume (30 Days)
656.2K
1.2M
Earning Date
05-12-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.21
$15.99
Revenue Next Year
$20.80
$10.00
P/E Ratio
$425.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.01
$10.65
52 Week High
$112.54
$17.86

Technical Indicators

Market Signals
Indicator
LIF
MMED
Relative Strength Index (RSI) 42.94 63.33
Support Level $37.47 $14.70
Resistance Level $55.84 N/A
Average True Range (ATR) 2.39 0.90
MACD -0.95 0.04
Stochastic Oscillator 10.20 73.31

Price Performance

Historical Comparison
LIF
MMED

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: